title: Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Gozzetti
authors.forename: Monica
authors.initials: M
authors.lastname: Bocchia
authors.forename: Simona
authors.initials: S
authors.lastname: Calabrese
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Pirrotta
authors.forename: Rosaria
authors.initials: R
authors.lastname: Crupi
authors.forename: Donatella
authors.initials: D
authors.lastname: Raspadori
authors.forename: Francesco
authors.initials: F
authors.lastname: Lauria
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D001752:Blast Crisis; D016313:Genes, abl; D006801:Humans; D000068877:Imatinib Mesylate; D016130:Immunophenotyping; D017404:In Situ Hybridization, Fluorescence; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate